XML 135 R116.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Contingencies and commitments (PCSK9 Antibody Patent Litigation) (Details) - patent | Nov. 30, 2018 | Mar. 18, 2016 | Dec. 15, 2014
--- | --- | --- | ---
Sanofi/Regeneron Patent Litigation [Member] |  |  |
Other Commitments [Line Items] |  |  |
Number of patents allegedly infringed |  |  | 7
Length of trial |  | 5 days |
Patent Disputes in the International Region [Member] |  |  |
Other Commitments [Line Items] |  |  |
Length of trial | 3 days |  |

X
- Definition Litigation Settlement, Length of Trial + References No definition available. + Details
Name: | amgn_LitigationSettlementLengthofTrial
Namespace Prefix: | amgn_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of entity's patents that another entity has allegedly infringed. + References No definition available. + Details
Name: | us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_OtherCommitmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_LitigationCaseAxis=amgn_SanofiRegeneronPatentLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=amgn_PatentDisputesintheInternationalRegionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |